Financial

Quris-AI’s Bio-AI Platform Integrated by Merck KGaA, Darmstadt, Germany for Preclinical Small Molecule Drug Safety Evaluation

Quris-AI to Provide Safety Assessments for Small Molecule Drug Candidates Before Initiating Clinical TrialsBOSTON and TEL-AVIV, Israel, Jan. 07, 2025…

1 year ago

CORRECTION: 2025’s Top-Rated EHR Vendors Across 40 Medical & Surgical Specialties: Black Book Insights Into Innovation and Client-Centric Excellence

Correction: This release has been updated to reflect accurate specialty-focused EHR top ratings. NextGen Healthcare has achieved five specialty-focused EHR…

1 year ago

ImageTrend Acquires biospatial

LAKEVILLE, Minn., Jan. 6, 2025 /PRNewswire/ -- Today ImageTrend announces the purchase of biospatial, based in Durham, NC for an…

1 year ago

U.S. Ambulatory EHR Market Report 2024-2031 – Integration of AI and ML Technologies to Offer Growth Opportunities for Market Players – ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "U.S. Ambulatory EHR Market Size, Share, Forecast, & Trends Analysis by Deployment Mode, Type Application, Practice, End User…

1 year ago

FDA Proposes Framework to Advance Credibility of AI Models Used for Drug and Biological Product Submissions

SILVER SPRING, Md., Jan. 6, 2025 /PRNewswire/ -- Today, the U.S. Food and Drug Administration issued draft guidance to provide recommendations…

1 year ago

FDA Issues Comprehensive Draft Guidance for Developers of Artificial Intelligence-Enabled Medical Devices

Guidance Shares Strategies to Address Transparency and Bias, while Providing Key Considerations and Recommendations on Product Design, Development and Documentation…

1 year ago

SIPS Healthcare Solutions’ New Multimillion-Dollar Tech Acquisition Brings Affordable AI-Driven Innovation to Safety Net and Community Hospitals Nationwide

DALLAS, Jan. 6, 2025 /PRNewswire/ -- In a landmark move to revolutionize sterile processing and perioperative services, SIPS Healthcare Solutions…

1 year ago

Veterans Benefits Administration awards medical disability examination services contract to Leidos QTC Health Services

RESTON, Va., Jan. 6, 2025 /PRNewswire/ -- Leidos (NYSE:LDOS) today announced that its wholly owned subsidiary, QTC Medical Services, operating under the…

1 year ago

AI/ML Innovations Inc. Announces Appointment of Peter Kendall as President and Chief Commercialization Officer

Accomplished Commercialization Leader to Drive Global Growth.Proven Expertise in Scaling Health Tech Businesses - Mr. Kendall Brings a Track Record…

1 year ago

Tempest Receives Orphan Drug Designation from the U.S. Food and Drug Administration for Amezalpat to Treat Patients with Hepatocellular Carcinoma (HCC)

BRISBANE, Calif., Jan. 06, 2025 (GLOBE NEWSWIRE) -- Tempest Therapeutics, Inc. (Nasdaq: TPST), a clinical-stage biotechnology company developing first-in-class1 targeted…

1 year ago